Indications and uses
relieves occasional constipation (irregularity) generally produces a bowel movement in 6-12 hours.
relieves occasional constipation (irregularity) generally produces a bowel movement in 6-12 hours.
take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage adults and children 12 years of age and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor
each tablet contains: calcium 30 mg store at 25 o C (77 o F); excursions permitted between 15 _ 30 o C (59 o_ 86 o F)
Sennosides 8.6 mg
Laxative
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| age | starting dosage | maximum dosage |
| adults and children 12 years of age and over | 2 tablets once a day | 4 tablets twice a day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil*, silicon dioxide*, sodium lauryl sulfate*, stearic acid*, talc*, triacetin*
*contains one or more of these ingredients
Call 1-877-753-3935 Monday-Friday 9AM-5PM EST
Compare to the active ingredient in Senokot®†
Regular Strength
SENNA LAXATIVE
(Standardized Senna Concentrate) Laxative Sennosides, 8.6 mg
TABLETS
†This product is not manufactured or distributed by Aviro Health L.P., distributor of Senokot®.
TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.
KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.
DISTRIBUTED BY FOODHOLD U.S.A., LLC
LANDOVER, MD 20785
1-877-846-9949
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41520-631 | 41520-631-10 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| TALC | 7SEV7J4R1U | IACT |
| SODIUM LAURYL SULFATE | 368GB5141J | IACT |
| TRIACETIN | XHX3C3X673 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2f1709e3-2a8a-4b9a-baad-ce452f0a8d22 | 62d07bae-1807-40e8-968c-bae70fed6a9f | 2025-06-24 | Warnings | 2f1709e3-2a8a-4b9a-baad-ce452f0a8d22 62d07bae-1807-40e8-968c-bae70fed6a9f |
Adverse event summaries are temporarily unavailable. Other product information remains available.